Capital Asset Advisory Services »

Vertex Pharmaceuticals Incorporated shares owned by Capital Asset Advisory Services

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Capital Asset Advisory Services from 13F filings

Historical chart of Capital Asset Advisory Services investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Capital Asset Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Capital Asset Advisory Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $265k 565 468.38
2022-03-31 $237k 909 260.73
2021-03-31 $257k 1.2k 214.52
2020-12-31 $108k 456 236.84

More positions owned by Capital Asset Advisory Services

Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Intl (IDEV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Gold Tr Ishares New (IAU)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr TRS FLT RT BD (TFLO)

View all positions for Capital Asset Advisory Services

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
FMR
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated